Humana Inc (HUM · NYSE)

HUM · MARKET VIEW

Market view · as of Aug 17, 2026

Revenue (TTM)
$145.68B
+26.2% YoY
Gross margin
13.7%
EPS (latest q)
$7.61
vs $6.22 est · beat
52-wk position
91.8%
-5.0% vs 52w high · -2.7% 1mo

Price (last ~year)

Humana Inc. (HUM) is currently executing a strategic reset of its Medicare Advantage business, involving the planned exit of approximately 600,000 members to support its 2028 margin targets. The company, which holds a market capitalization of $46.72 billion, reported $40.87 billion in revenue for the quarter ending June 30, 2026, contributing to a trailing twelve-month revenue of $145.68 billion. Shares are trading at $389.05, reflecting a 25.6% gain over the past three months against an analyst price target of $416.43.

Valuation

Market cap
$46.72B
P/E
36.77
PEG
2.204
P/B
2.432
P/S
0.321
Beta
0.74
Analyst target
$416.43

Quality & returns

Gross margin
13.7%
Operating margin
3.5%
Profit margin
0.9%
ROE
6.9%
ROA
3.9%

Price movement

Last
$389.05
1-month
-2.7%
3-month
+25.6%
RSI (14)
53
vs SMA200
+44.7%
52-wk position
91.8% -5.0% vs high

Quarterly trajectory

Revenue by quarter (oldest → newest)

QuarterRevenueOp incomeNet incomeEBITDA
2026-06-30$40.87B$1.36B$693.0M$1.31B
2026-03-31$39.65B$1.58B$1.19B$1.97B
2025-12-31$32.52B$-1.02B$-796.0M$-685.0M
2025-09-30$32.65B$108.0M$195.0M$480.0M

Recent news

Sources this view read

  • fundamentals Company overview & valuation (Alpha Vantage OVERVIEW)
  • filing Quarterly financial statements (Alpha Vantage INCOME/BALANCE/CASH)
  • earnings Reported earnings history (Alpha Vantage EARNINGS)
  • prices Adjusted daily prices (Alpha Vantage TIME_SERIES_DAILY_ADJUSTED)

Other snapshots